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Human bitter taste receptors (hTAS2Rs) are the second largest group of chemosensory G-protein coupled
receptors (25 members). hTAS2Rs are expressed in many tissues (e.g. tongue, gastrointestinal tract,
respiratory system, brain, etc.), performing a variety of functions, from bitter taste perception to hormone
secretion and bronchodilation. Due to the lack of experimental structural information, computations are
currently the methods of choice to get insights into ligandereceptor interactions. Here we review our
efforts at predicting the binding pose of agonists to hTAS2Rs, using state-of-the-art bioinformatics ap-
proaches followed by hybrid Molecular Mechanics/Coarse-Grained (MM/CG) simulations. The latter
method, developed by us, describes atomistically only the agonist binding region, including hydration,
and it may be particularly suited to be used when bioinformatics predictions generate very low-
resolution models, such as the case of hTAS2Rs. Our structural predictions of the hTAS2R38 and
hTAS2R46 receptors in complex with their agonists turn out to be fully consistent with experimental
mutagenesis data. In addition, they suggest a two-binding site architecture in hTAS2R46, consisting of
the usual orthosteric site together with a “vestibular” site toward the extracellular space, as observed in
other GPCRs. The presence of the vestibular site may help to discriminate among the wide spectrum of
bitter ligands.
© 2017 The Authors. Publishing services by Elsevier B.V. on behalf of Vietnam National University, Hanoi.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The 25 human bitter taste receptors (hTAS2Rs) [1,2] constitute
the second largest group of chemosensory G-protein coupled re-
ceptors (GPCRs), in turn the largest membrane protein superfamily,gy, University of Verona, Ca'
ine, Institute for Advanced
and Medicine INM-9, For-
rgetti), m.alfonso-prieto@fz-
onal University, Hanoi.
y Elsevier B.V. on behalf of Vietnamwith about 850 members in humans. hTAS2Rs are found in many
different tissues of the human body [3e5]. These include the
plasma membrane of the type II taste receptor cells (from which
their name, TAS2Rs, comes from), located in the taste buds of the
tongue [1,6e8], the respiratory system [9e11], the gastrointestinal
tract [12,13] the endocrine system [13] and the brain [14]. Hence,
hTAS2Rs play different roles, ranging from perception of bitter
taste, to detection of toxins [15], to bronchodilation [16], and to
hormone secretion [17]. hTAS2Rs can recognize hundreds of
structurally diverse agonists using a combinatorial coding scheme
[18,19]. One hTAS2R is able to recognize more than one agonist
[20,21], and one agonist can be recognized by more than one
hTAS2R [20]. Understanding the details of hTAS2Rseagonists in-
teractions may provide important hints on the effect of genetic
variability on bitter taste perception, and new opportunities forNational University, Hanoi. This is an open access article under the CC BY license
E. Suku et al. / Journal of Science: Advanced Materials and Devices 2 (2017) 15e2116designing more subtype-speciﬁc ligands [22,23] and novel thera-
pies against diseases related to hTAS2Rs' dysfunction, e.g. asthma
or chronic rhinosinusitis [4,5].
hTAS2Rs, as all GPCRs, are made up of seven transmembrane
helices arranged in a helix-bundle shape and connected by three
extracellular loops (ECLs) and three intracellular loops (ICLs) [24].
Agonist binding to the receptor's binding site (called orthosteric
site) facilitates conformational changes towards an “active state”.
The latter allows the activation of downstream effectors [7,25]. The
location of the orthosteric site in hTAS2Rs is similar to other re-
ceptors of the largest GPCR class, class A [26e31]. However, because
of the low sequence similarity between hTAS2Rs and the other
GPCRs, it has not been clearly established yet if hTAS2Rs belong to
class A [32e34] or class F [27,35,36] GPCRs. These proteins could
even constitute a different family [27].
At present no experimental structural information is available
for hTAS2Rs. Therefore, any attempt at understanding the hTAS2R-
agonist complexes has to rely on computational approaches. Bio-
informatics techniques, such as homology modeling [37], along
with molecular docking [38e40], could in principle provide in-
sights into agonist/antagonist binding. Unfortunately, however, the
sequence identity between bitter taste receptors and the possible
templates is extremely low (~10e17% with any of the 42 unique X-
ray structures as of February 2017 (http://blanco.biomol.uci.edu/
mpstruc/)). As a consequence, the construction of reliable align-
ments between the target sequence and the available structural
templates is challenging [41e43]. Moreover, even with a good
sequence alignment, the orientation of the side chains in the
orthosteric binding site, which is key for proteineligand in-
teractions, is not accurately modeled [44,45]. This hinders the
correct prediction of docking poses. In addition, current bioinfor-
matics and docking algorithms face at times limitations (such as the
lack of protein ﬂexibility and hydration [46,47]), which may further
limit the power of the predictions, especially in light of the fact that
factors such as conformational dynamics [48] and water molecules
[49,50] play a crucial role for ligand binding and receptor activation.
A way to overcome these difﬁculties is to combine these static
computational approaches with molecular simulation techniques,
such as molecular dynamics (MD) and enhanced sampling [51e53].
These methods may explore efﬁciently the conformational space,
including hydration and ligandeprotein interactions. All-atom MD
has been successfully used in high quality homology models (i.e.
based on a template with sequence identity above 60%) [48,54,55];
however, it may provide far less satisfying results when the protein
structure is a homology model based on a low sequence identity
template (as it is the case for hTAS2Rs). Here, the side chains'
rotamers are poorly predicted and often their relaxation requires
longer time scales that cannot be reached with atomistic MD.
Coarse-grained (CG)-based MD can be used to sample longer
timescales [56e59], yet it cannot describe in detail the molecular
recognition events between protein and ligand. A way to overcome
these limitations is represented by the combination of the two
aforementioned techniques [60e67]. In this context, our group has
developed a hybrid “Molecular Mechanics/Coarse-Grained” (MM/
CG) method for reﬁnement of GPCRs homology models [63,68,69].
Here, the system is modeled at two different resolutions. While
ligand, binding site residues and surrounding water molecules are
treated using an atomistic force ﬁeld, the rest of the protein is
described at a CG level. A coupling scheme is then used to connect
the two regions at the boundary. This MM/CG method maintains
the atomistic resolution needed to describe correctly the pro-
teineligand interactions at the binding site, while allowing a larger
conformational sampling and a reduced computational cost
compared to an all-atom simulation. The presence of themembrane is mimicked by introducing ﬁve repulsive walls. Two
planar walls coincide with the height of the head groups of the
membrane lipids, two hemispheric walls set a limit on the extra-
cellular and intracellular ends of the protein and the last wall fol-
lows the initial shape of the interface between protein and
membrane [70e72].
The accuracyof theMM/CGmethod in reproducingbindingposes
andproteinﬂuctuationswasestablished inourearlywork [68].Here,
wewill presentmore recent predictions forwidely studied hTAS2Rs,
which were successfully validated against extensive mutagenesis
data [73e75]. Speciﬁcally, we investigate hTAS2R46 [76], a promis-
cuousbitter taste receptor [20,73,77] that candetectbittermolecules
belonging to several different chemical classes, and hTAS2R38
[74,75], a receptor that recognizes agonists containing an isothio-
cyanate or thiourea group [20,77,78]. Given their different receptive
range, these two receptors constitute excellent contrasting test cases
to assess the applicability of the MM/CG methodology to study
ligand binding in human bitter taste receptors.
2. Materials and methods
Our web-server GOMoDO [79] performs automatically both the
homology modeling and molecular docking steps, by combining
state-of-the-art bioinformatics tools for GPCRs. In particular,
GOMoDO uses the proﬁleeproﬁle HMM algorithm (for database
search and target-template alignment) and the MODELLER pro-
gram [80] (for protein homology model construction), followed by
information-driven ﬂexible docking of ligands through the
HADDOCK program [81]. This protocol was used to produce the
initial model of hTAS2R46 in complex with one of its agonists,
strychnine, as well as the models of hTAS2R38 in complex with its
two agonists, namely propylthiouracil (PROP) and phenylthiocar-
bamide (PTC). Speciﬁcally, the MODELLER algorithm [80] was used
to generate 200 models of hTAS2R46 and hTAS2R38, applying a
single-template or multiple-template approach, respectively
[74e76]. Then, a clustering analysis was performed to identify
“representative” receptor models, using as criteria both the MOD-
ELLER quality scores and available experimental site-directed
mutagenesis data. In the case of hTAS2R46, one single model was
taken as representative, whereas for hTAS2R38 two models were
selected, which mainly differ in the conformation of the ECL2. The
agonists, strychnine for hTAS2R46 and PROP and PTC for hTAS2R38,
were docked into the modeled receptor structures using HADDOCK
[81]. Information about the putative binding residues was used to
drive the docking. For hTAS2R46 the putative binding residues
were predicted using FPOCKET [82], whereas for hTAS2R38, they
were selected based on previous bioinformatics and site-directed
mutagenesis studies [74]. In the docking protocol, ﬁrst 1000
structures were generated in the rigid body step and, then, the top
scoring 200 complexes were further optimized using a ﬂexible
simulated annealing step, followed by a ﬁnal reﬁnement step in
explicit water. Next, a clustering analysis was performed to identify
the best initial model, that is, the structure of the most populated
cluster with the lowest binding energy. The best docking models
then underwent MM/CG simulations [63,68,69]. In these multiscale
approach, ligand, binding site residues and surrounding water
molecules were treated using the GROMOS96 atomistic force ﬁeld
[83], whereas the rest of the protein was described at a CG level,
including only the Ca atoms of the amino acids and using a Go-like
model [84]. For hTAS2R46, the model of the receptorestrychnine
complex was used to set up three replicas, with different initial
velocities; a 1 ms-long MM/CG simulationwas run for each [76]. For
hTAS2R38, the models for each receptor-agonist complex (PROP
and PTC) were submitted to MM/CG simulations; for each complex,
E. Suku et al. / Journal of Science: Advanced Materials and Devices 2 (2017) 15e21 17two replicas, differing only in the initial velocities, were run for
0.6 ms [75].
3. Results and discussion
3.1. hTAS2R46 in complex with strychnine
hTAS2R46 is a receptor involved not only in bitter taste
perception, but also in ciliary beat frequency and clearance of mi-
croorganisms in the airways [85] and in blood pressure control in
vascular smooth muscle cells [86]. hTAS2R46 is a promiscuous re-
ceptor [20,73]: it can detect bitter molecules belonging to several
different chemical classes. How hTAS2R46 can discriminate this
wide range of agonists from other bitter molecules is still an open
question. Prof. Meyerhof and coworkers suggested the existence of
an “access control” within the extracellular opening of the receptor
[73] that may act as a selectivity ﬁlter. In an effort at providing a
molecular basis of such “access control”, we carried out bioinfor-
matics and MM/CG calculations of hTAS2R46 in complex with its
agonist strychnine [76].
Interestingly, our simulations identify two different binding
poses. In the ﬁrst pose (Fig. 1a), the ligand is localized in a region
that coincides with the orthosteric site identiﬁed in the X-ray
structures of class A GPCRs in complex with their corresponding
agonists. Moreover, like in hTAS2R38 (see below), our MM/CG
simulations predict several binding pocket residues, which are
subsequently validated through experiments [76]. In particular,
Tyr241 and Asn92, which are also highly conserved in the hTAS2R
family, are identiﬁed in the orthosteric cavity. Tyr241 forms a p-
stacking interaction with the aromatic ring of the strychnine, as
well as a H-bondwith Asn92. Consistently, themutations Asn92Gln
and Tyr241Phe in hTAS2R46 reduce the receptor activation levels or
abolish the signal completely, respectively, whereas the Tyr241Trp
lowers the EC50 value. Thus, according to these ﬁndings, the
interaction between Tyr241 and Asn92 could play a role in receptor
activation more than in ligand selectivity. In this regard, the latter
residue has been shown to be crucial for receptor activation also in
hTAS2R43 [87].
In the second pose (Fig. 1b), the ligand is positioned in the
extracellular region, in a site that resembles the allosteric binding
cavity in class A GPCRs [26,28,88e95], which we called “vestibular”Fig. 1. Human TAS2R46 in complex with its agonist strychnine bound in the vestibular (a) an
(c). In panels A and B, strychnine is shown in cyan and the regions of the protein treated at
yellow, the atomistic (MM) part of the receptor and, in blue, the coarse-grained (CG) pa
extracellular part of the protein, in order to explicitly account for the hydration of the bindin
the position of the lipid bilayer, mimicked by two planar walls in our MM/CG setup. For t
intracellular ends of the protein, as well as the wall following the initial shape of the intersite. Our simulations identify Leu71 and Asn176 as part of the
vestibular site and provide a molecular level explanation of previ-
ous mutagenesis experimental data [73]. Therefore, the decreased
receptor activation for the Leu71Phe mutant is most likely due to a
reduction of the volume of the vestibular cavity, whereas, for the
Asn176Ala mutant, it is probably caused by the disruption of a H-
bond network involving Asn176 and ECL2, a loop known to be
involved in ligand binding and receptor activation in GPCRs
[89,96,97].
Importantly, some residues known experimentally as function-
ally important, i.e. Leu71 and Asn176 [73], interact with strychnine
only in the vestibular cavity. Hence, the experimental mutagenesis
data cannot be rationalized by taking into account only the ca-
nonical orthosteric binding site, and, instead, the two topographi-
cally distinct ligand binding cavities need to be considered.
Therefore, hTAS2R46 features two binding sites (orthosteric and
vestibular), and both cavities may contribute to the selectivity of
the receptor. In this regard, hTAS2R46 has been found to recognize
at least 28 different agonists [77], belonging to diverse chemical
classes. Given this promiscuity, it is unlikely the orthosteric binding
site alone could discriminate this wide variety of compounds. We
hypothesize that the presence of a second, vestibular site can
provide additional proteineligand contacts that will help to ﬁlter
the appropriate agonists out of the pool of more than 100 bitter
compounds known [20].
In order to assess whether this two-step mechanism could also
apply to other bitter taste receptors, we performed a bioinformatics
analysis of the conservation across the hTAS2R family of the resi-
dues identiﬁed for hTAS2R46 as functionally important (Fig. 2). We
found that more than 50% of these residues were conserved in at
least two hTAS2Rs. Interestingly, while four of the conserved resi-
dues (positions 2.65, 3.26, 3.29 and 5.39, following the generic
GPCR numbering [98]) were found to be localized only in the pu-
tative vestibular binding site (in red in Fig. 2), ﬁve other residues
(3.33, 3.36, 3.37, 3.40 and 7.42) were placed only in the orthosteric
binding site (in green in Fig. 2). These analyses thus suggest that the
two-site architecture may also be present in other human bitter
taste receptors, besides hTAS2R46. This could be related to the
ability of most hTAS2Rs to detect more than one agonist (see
Table 1). Two sites can offer more ligand recognition points than a
single one, thus helping to select the appropriate agonists.d orthosteric (b) binding sites, together with the 2D structure of the strychnine agonist
different resolutions in our MM/CG simulations are displayed with different colors: in
rt (see the Materials and methods section). A water droplet (in red) surrounds the
g site. The two horizontal black lines delimit the transmembrane part of the receptor or
he sake of clarity, the two hemispheric walls setting a limit on the extracellular and
face between protein and membrane, are not shown.
Fig. 2. Position of residues in the hTAS2R46 receptor for which experimental mutagenesis data are available. In green, residues belonging to the orthosteric binding site (3.35, 3.36,
3.37, 3.40, 3.41, 5.46 and 7.42), in red those located in the vestibular site (2.61, ECL1, 3.26, 3.29, 5.39, 5.40 and 6.55), and in yellow residues common to both binding cavities (3.31,
3.32, 3.33, 5.42, 5.43, 6.51, 6.52 and 7.39).
Table 1
25 human bitter taste receptors with their respective number of agonists. Data compiled from the BitterDB [99] (http://bitterdb.agri.huji.ac.il) and reference [77]. For some
receptors (markedwith*), two names are given; the ﬁrst one corresponds to the BitterDB and the second one is the one used in reference [77]. Note also that four receptors still
remain orphan (i.e. number of identiﬁed ligands is 0).
Receptor name Number of ligands Receptor name Number of ligands
BitterDB Reference [77] BitterDB Reference [77]
TAS2R1 35 12 TAS2R40 11 5
TAS2R3 1 1 TAS2R41 1 1
TAS2R4 22 12 TAS2R42 0 0
TAS2R5 1 3 TAS2R43 16 13
TAS2R7 6 7 TAS2R44/31* 8 6
TAS2R8 3 3 TAS2R45 0 0
TAS2R9 3 2 TAS2R46 27 28
TAS2R10 31 29 TAS2R47/30* 10 7
TAS2R13 2 1 TAS2R48 0 0
TAS2R14 47 34 TAS2R49/20* 2 1
TAS2R16 10 5 TAS2R50 2 1
TAS2R38 21 24 TAS2R60/56* 0 0
TAS2R39 20 11
E. Suku et al. / Journal of Science: Advanced Materials and Devices 2 (2017) 15e2118Nonetheless, further in silico and wet lab experiments are neces-
sary to conﬁrm whether the two-site architecture is present across
the whole hTAS2R family.
3.2. hTAS2R38 in complex with its agonists propylthiouracil (PROP)
and phenylthiocarbamide (PTC)
hTAS2R38 is a receptor involved in bitter taste perception in the
tongue, as well as other extra-oral roles, such as anti-microbial
response in the sinonasal cavity [10,15] and activation of tran-
scription factors in pancreatic tumor cells [100]. Supporting the
putative ectopic roles of hTAS2R38, different hTAS2R38 poly-
morphisms have been associated with several pathologies, such as
predisposition to chronic rhinosinusitis [101], risk of dental caries
[102], alteration of alcohol intake [103], alteration of body mass
index [104], and ingestive behavior in women [105]. hTAS2R38 is a
chemical group-speciﬁc bitter taste receptor [77], since it detects
bitter agonists containing an isothiocyanate or thiourea group.
Here we investigate the receptor in complex with two typical
agonists, PTC and PROP, by MM/CG simulations (Fig. 3a). The cal-
culations turned out to be consistent with functional data for nine
mutants [74,75]. In particular, we observed that the Asn103 side-
chain forms a H-bond with both ligands (see Fig. 3b). This is
consistent with the experimental data showing that Asn103Ala,Asn103Val and Asn103Asp mutations result in EC50 larger values
than the WT for both agonists: the ﬁrst two mutations impair the
formation of the H-bond, whereas the presence of the Asp in po-
sition 103 causes a repulsive electrostatic interaction with the
partially negatively charged sulfur atom of the two ligands (see
Fig. 3b). The simulations also show that Ser259 is in close proximity
to the ligand without any direct interaction. Therefore, the larger
EC50 value of Ser259Val mutant compared to the WT is probably
due to the presence of a bulkier residue that could hinder binding,
rather than to the loss of a H-bond. Indeed, mutation of Ser259 into
Ala, a residue similar in size, maintains EC50 values similar to the
WT. The EC50 values of Trp99Ala, Trp99Val and Met100Ala are
similar to those of WT for both agonists, while those of the
Met100Val mutant are larger than the WT. The simulations suggest
that Trp99 and Met100 do not interact directly with the ligand,
though they are located close to the binding pocket and, thus, when
Met100 is mutated into a branched amino acid, Val, it may occlude
the binding site.
Based on the results of the MM/CG calculations, new mutations
were designed so as to affect the proteineligands interactions.
Residues Asn179, Arg181 and Asn183 do not show any interactions
with either of the two agonists during the MM/CG simulations, and
hencemutation of these residues into Ala or Val are not expected to
alter signiﬁcantly the EC50 values measured for the WT.
Fig. 3. hTAS2R38 in complex with its agonist PTC in the orthosteric site (a). PTC is shown in cyan and the regions of the protein treated at different resolutions in our MM/CG
simulations are displayed with different colors: in yellow, the atomistic (MM) part of the receptor and, in blue, the coarse-grained (CG) part (see the Materials and methods section).
A water droplet (in red) surrounds the extracellular part of the protein, in order to explicitly account for the hydration of the binding site. The two horizontal black lines delimit the
transmembrane part of the receptor or the position of the lipid bilayer, mimicked by two planar walls in our MM/CG setup. For the sake of clarity, the two hemispheric walls setting
a limit on the extracellular and intracellular ends of the protein, as well as the wall following the initial shape of the interface between protein and membrane, are not shown. (b) 2D
structures of PROP (top) and PTC (bottom).
E. Suku et al. / Journal of Science: Advanced Materials and Devices 2 (2017) 15e21 19Experiments performed in that work [75] show that this is indeed
the case. In contrast, residues Phe197, Phe264 and Trp201 establish
pep stacking interactions with both agonists during the MM/CG
simulations, and thus we can predict that the EC50 values of
Phe197Val, Phe264Ala, Phe264Val and Trp201Leu are larger than
those of the WT. Also in this case, experiments show the validity of
these predictions.
Interestingly, Asn103, which forms a H-bond with the agonists
in hTAS2R38 [74,75], is highly conserved across hTAS2Rs, and has
also been shown to be involved in ligand binding in hTAS2R46 [73],
hTAS2R31 [73,87] hTAS2R43 [87] and hTAS2R16 [106]. Moreover,
Phe264 and Trp99 are found to shape the ligand binding pocket for
both hTAS2R38 agonists, PTC and PROP [75]. These two evidences
support the hypothesis of Meyerhof and coworkers that different
agonists may have similar orthosteric binding pockets in hTAS2Rs
[73].
In conclusion, our MM/CG simulations results on hTAS2R38 are
consistent with more than 20 mutagenesis data. These predictions
would have been impossible to achieve using the bioinformatics
approach only. In particular, the poses predicted by bioinformatics
lack key H-bond and pep stacking ligand/protein interactions. This
points to the relevance of molecular dynamics simulations for the
structural reﬁnement of these receptors' models. The fact that our
simulations were not able to capture the vestibular binding site in
hTAS2R38 may imply either that only one cavity is needed for the
less promiscuous hTAS2R38 receptor or that more simulations are
needed.
4. Conclusion
Our MM/CG-based predictions provide a rather detailed
description of hTAS2R46- and hTAS2R38-agonist interactions,
consistent with mutagenesis data [74e76]. They also allow us to
hypothesize that hTAS2R46 features a two-site architecture, with
an orthosteric and a vestibular binding site, similar to what has
been already suggested for other members of the class A GPCRs
[26,28,88e95]. The existence of a second binding site may becrucial to recognize the wide variety of hTAS2R46 agonists, by
providing a two-step authentication mechanism for this promis-
cuous receptor. In contrast, the vestibular site was not captured by
our simulations of hTAS2R38, perhaps because it is not required for
a more selective receptor [77]. Nonetheless, a conservation analysis
of the binding residues across the whole hTAS2R family suggests
that this two-site architecture might also be present in other
hTAS2Rs. Therefore, further simulations and mutagenesis studies
are necessary to clarify this point.Acknowledgments
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